NCT07184944

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

RecruitingPHASE3INTERVENTIONAL

Trial Details

Start: 2026-01-22Est. Completion: 2029-08-13

Enrollment target: 751 participants

Locations

Peak Gastroenterology Associates - Colorado Springs-Site Number: 8400039, Colorado Springs, Colorado, United States
Clinical Research of Osceola-Site Number: 8400013, Kissimmee, Florida, United States
Columbus Clinical Services LLc-Site Number: 8400038, Miami, Florida, United States
Bioresearch Partner-Kendale Lakes-Site Number: 8400053, Miami, Florida, United States
Orlando Health, Inc., Digestive Health Institute-Site Number: 8400084, Orlando, Florida, United States
NMC Research LLC-Site Number: 8400033, Tampa, Florida, United States
Illinois Gastroenterology Group d/b/a GI Alliance - Gurnee-Site Number: 8400049, Gurnee, Illinois, United States
Gastroenterology Health Partners, PLLC - New Albany-Site Number: 8400100, New Albany, Indiana, United States
GI Alliance - Baton Rouge-Site Number: 8400129, Baton Rouge, Louisiana, United States
Texas Digestive Disease Consultants, PLLC d/b/a GI Alliance - Mandeville-Site Number: 8400128, Mandeville, Louisiana, United States
GI Alliance - Metairie-Site Number: 8400124, Metairie, Louisiana, United States
Delta Research Partners-Site Number: 8400087, Monroe, Louisiana, United States

Inflammatory Bowel Diseases (IBD)Crohn DiseaseColitis, Ulcerative

Difficult-to-treat inflammatory bowel disease (DTT-IBD) represents a heterogeneous group of patients with treatment-refr…

Multiple LocationsEst. completion Oct 31, 2032

Inflammatory Bowel Disease

This study evaluates oral Lactobacillus reuteri as an adjunct therapy for 2 months. Endoscopic assessments will be perfo…

Suqian, ChinaCompleted Mar 30, 2026

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.